Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia
- 1 April 1975
- Vol. 35 (4) , 1066-1073
- https://doi.org/10.1002/1097-0142(197504)35:4<1066::aid-cncr2820350408>3.0.co;2-r
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- IRRADIATION, METHOTREXATE TOXICITY, AND THE TREATMENT OF MENINGEAL LEUKÆMIAThe Lancet, 1973
- Prevention of central nervous system leukemia by irradiationCancer, 1973
- Immunosuppressive Consequences of Radiotherapy and Chemotherapy in Patients with Acute Lymphoblastic LeukaemiaBMJ, 1973
- Cerebrospinal Axis Radiation Therapy for Meningeal Leukemia with Tumor Dose Levels in the Range of 2,000 RadsRadiology, 1972
- Paraplegia following intrathecal chemotherapyCancer, 1972